Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Puma Biotechnology Inc (NASDAQ: PBYI) closed the day trading at $4.62 down -4.94% from the previous closing price of $4.86. In other words, the price has decreased by -$4.94 from its previous closing price. On the day, 0.58 million shares were traded. PBYI stock price reached its highest trading level at $4.88 during the session, while it also had its lowest trading level at $4.355.
Ratios:
For a better understanding of PBYI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.28. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.46. In the meantime, Its Debt-to-Equity ratio is 2.17 whereas as Long-Term Debt/Eq ratio is at 1.19.
Goldman Downgraded its Neutral to Sell on October 08, 2019, whereas the target price for the stock was revised from $24 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’24 when AUERBACH ALAN H sold 41,396 shares for $4.49 per share. The transaction valued at 185,698 led to the insider holds 6,936,947 shares of the business.
NOUGUES MAXIMO F sold 15,682 shares of PBYI for $70,348 on Jan 03 ’24. The Chief Financial Officer now owns 128,666 shares after completing the transaction at $4.49 per share. On Jan 03 ’24, another insider, Ludwig Jeffrey Jerome, who serves as the Chief Commercial Officer of the company, sold 12,956 shares for $4.49 each. As a result, the insider received 58,119 and left with 99,970 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBYI now has a Market Capitalization of 234440976. As of this moment, Puma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.36, and their Forward P/E ratio for the next fiscal year is 18.99. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98 while its Price-to-Book (P/B) ratio in mrq is 4.37.
Stock Price History:
Over the past 52 weeks, PBYI has reached a high of $7.73, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is -13.97%, while the 200-Day Moving Average is calculated to be 9.63%.
Shares Statistics:
Over the past 3-months, PBYI traded about 582.11K shares per day on average, while over the past 10 days, PBYI traded about 272170 shares per day. A total of 47.65M shares are outstanding, with a floating share count of 34.71M. Insiders hold about 28.05% of the company’s shares, while institutions hold 54.93% stake in the company. Shares short for PBYI as of 1713139200 were 3325691 with a Short Ratio of 5.71, compared to 1710460800 on 3333130. Therefore, it implies a Short% of Shares Outstanding of 3325691 and a Short% of Float of 8.09.
